Cargando…
Epi-Drugs in Heart Failure
Unveiling the secrets of genome’s flexibility does not only foster new research in the field, but also gives rise to the exploration and development of novel epigenetic-based therapies as an approach to alleviate disease phenotypes. A better understanding of chromatin biology (DNA/histone complexes)...
Autores principales: | Gorica, Era, Mohammed, Shafeeq A., Ambrosini, Samuele, Calderone, Vincenzo, Costantino, Sarah, Paneni, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326055/ https://www.ncbi.nlm.nih.gov/pubmed/35911511 http://dx.doi.org/10.3389/fcvm.2022.923014 |
Ejemplares similares
-
Epigenetic remodeling in heart failure with preserved ejection fraction
por: Ambrosini, Samuele, et al.
Publicado: (2022) -
Epigenetic Control of Mitochondrial Function in the Vasculature
por: Mohammed, Shafeeq A., et al.
Publicado: (2020) -
Mitochondrial epigenetics in aging and cardiovascular diseases
por: Mongelli, Alessia, et al.
Publicado: (2023) -
Inflammation in Metabolic Cardiomyopathy
por: Wenzl, Florian A., et al.
Publicado: (2021) -
The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapies
por: Costantino, Sarah, et al.
Publicado: (2020)